Continuous forms of renal replacement therapy (CRRT) have become established as the
treatment of choice for supporting critically ill patients with acute kidney injury. Typically …

Citrate has many characteristics of the ideal anticoagulant for hemodialysis. In addition to
immediate and complete anticoagulation in the dialysis circuit, citrate has important effects …

Severe kidney disease results in retention of uremic toxins that inhibit key enzymes for lipid
breakdown such as lipoprotein lipase (LPL) and hepatic lipase (HL). For patients in …

Background The majority of citrate protocols for hemodialysis (HD) use calcium (Ca)-free
dialysate, a limited number use dialysate with Ca, aiming to simplify the procedure. This …

Background Recommended regular saline flushing presents clinical ineffectiveness for
hemodialysis (HD) patients at high risk of bleeding with heparin contraindication. Regional …

Introduction Intensive care participants that need dialysis frequently suffer from increased
risk of bleeding. Standard intermittent haemodialysis (SHD) includes anticoagulation to …

Background Cardiovascular diseases are the dominant cause of morbidity in hemodialysis
(HD) patients. Unless sufficient anticoagulation is used during HD, clotting may appear. The …

In plasma exchange (PE), contrary to dialysis, there is no ultrafiltration, and the volume of
anticoagulant contributes to volume overload of the patient and might also reduce PE …

Since 2012, citrate anticoagulation is the recommended anticoagulation strategy for
continuous renal replacement therapy (CRRT). The main drawback using citrate as …

We proposed a combination of convective and diffusive transport mechanisms as high cut‐
off (HCO) post‐dilution hemodiafiltration dialysis technique to optimize serum …